Cargando…
Nephrotoxicities
Nephrotoxic medication exposure is nearly ubiquitous in hospitalized patients and represents one of the most common causes of acute kidney injury (AKI) in the hospitalized setting. Although provision of medications that are nephrotoxic has led to improved outcomes in terms of treatment of underlying...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247779/ https://www.ncbi.nlm.nih.gov/pubmed/28163909 http://dx.doi.org/10.12688/f1000research.10192.1 |
_version_ | 1782497140674658304 |
---|---|
author | Goldstein, Stuart L. |
author_facet | Goldstein, Stuart L. |
author_sort | Goldstein, Stuart L. |
collection | PubMed |
description | Nephrotoxic medication exposure is nearly ubiquitous in hospitalized patients and represents one of the most common causes of acute kidney injury (AKI) in the hospitalized setting. Although provision of medications that are nephrotoxic has led to improved outcomes in terms of treatment of underlying illness, unnecessary nephrotoxic medication exposure can be viewed as a potentially modifiable adverse safety event if AKI can be prevented. The advancements in electronic health record development, standardization of AKI definitions, and the ability to identify AKI risk and development in near real time provide opportunities to reduce harm from nephrotoxicity. |
format | Online Article Text |
id | pubmed-5247779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | F1000Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-52477792017-02-02 Nephrotoxicities Goldstein, Stuart L. F1000Res Review Nephrotoxic medication exposure is nearly ubiquitous in hospitalized patients and represents one of the most common causes of acute kidney injury (AKI) in the hospitalized setting. Although provision of medications that are nephrotoxic has led to improved outcomes in terms of treatment of underlying illness, unnecessary nephrotoxic medication exposure can be viewed as a potentially modifiable adverse safety event if AKI can be prevented. The advancements in electronic health record development, standardization of AKI definitions, and the ability to identify AKI risk and development in near real time provide opportunities to reduce harm from nephrotoxicity. F1000Research 2017-01-19 /pmc/articles/PMC5247779/ /pubmed/28163909 http://dx.doi.org/10.12688/f1000research.10192.1 Text en Copyright: © 2017 Goldstein SL http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Goldstein, Stuart L. Nephrotoxicities |
title | Nephrotoxicities |
title_full | Nephrotoxicities |
title_fullStr | Nephrotoxicities |
title_full_unstemmed | Nephrotoxicities |
title_short | Nephrotoxicities |
title_sort | nephrotoxicities |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247779/ https://www.ncbi.nlm.nih.gov/pubmed/28163909 http://dx.doi.org/10.12688/f1000research.10192.1 |
work_keys_str_mv | AT goldsteinstuartl nephrotoxicities |